KIRKLAND, WA--(Marketwire - September 17, 2008) - Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), today announced that doctors at St. John Hospital and Medical Center (SJH&MC) in Detroit have treated the first patient in the United States with the Jetstream™ Pathway PV™ Atherectomy System, a peripheral atherectomy catheter designed to remove artery-clogging plaque for patients suffering from PAD in the lower limbs. Recently cleared by the U.S. Food & Drug Administration (FDA), Jetstream is the first atherectomy device on the market capable of treating an entire spectrum of disease found in the PAD patient, including hard and soft plaque, calcium, thrombus and fibrotic lesions with consistent clinical results.
